26 Aug 2008 Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
21 Aug 2008 NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
21 Aug 2008 VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
21 Aug 2008 VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
20 Aug 2008 BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
19 Aug 2008 EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
16 Aug 2008 Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases
14 Aug 2008 Bioms Medical Announces Positive Interim Analysis on Phase III Trial of Dirucotide (MBP8298) For Multiple Sclerosis
07 Aug 2008 DOR BioPharma Announces Initiation of Second Human Clinical Trial for RiVax(TM), Its Ricin Toxin Vaccine
06 Aug 2008 Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
05 Aug 2008 Bionor Immuno have started a Vacc-4x Phase IIB TOC study in US and Europe with enrollment of 345 patients.
03 Aug 2008 Bioms Medical Completes Patient Recruitment in Phase III U.S. Multiple Sclerosis Trial
28 Jul 2008 Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
23 Jul 2008 Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
22 Jul 2008 Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
18 Jul 2008 Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
16 Jul 2008 AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
13 Jul 2008 Oxford BioMedica Announces Data Safety Monitoring Board Reccomendation for TroVax(R) Phase III Trist Study
10 Jul 2008 CYT003-QbG10 monotherapy for the treatment of allergic diseases is safe and efficacious in placebo-controlled phase II study
10 Jul 2008 Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
08 Jul 2008 Opexa’s Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board
08 Jul 2008 Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
01 Jul 2008 IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
30 Jun 2008 GlaxoSmithKline responds to FDA on Cervarix(R) and plans to submit final study data for approval
30 Jun 2008 Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up